Licorice Root for Health & Longevity - Quick Reference Sheet

Licorice Root for Health & Longevity

Created on 08/27/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

Licorice root is two things under one name. Whole root carries the sweet compound that blocks the enzyme switching off the body's main stress hormone — the source of every serious harm on record: rising blood pressure, potassium loss, swelling, dangerous heart rhythms. Processed forms strip it out, keeping digestive benefit. Ageing claims rest on cell cultures and worms. (Full Review)

Protocol

Whole licorice root, conventional herbal dose
1–5 g dried root daily
Tea or capsules, roughly 30–150 mg glycyrrhizin. Rarely beyond 4–6 continuous weeks.
Deglycyrrhizinated licorice for digestive use
380–760 mg chewed
20 minutes before each of two or three meals. The chewable form matters.
Best time of day
Morning, with or after breakfast
Aligns the cortisol-prolonging effect with the natural morning peak and avoids evening alertness that disrupts sleep.
Time to effect
Postoperative sore throat
Within 24 hours
Gargled or sucked before general anaesthesia; measured 24 hours after surgery.
Digestive symptom relief
7–14 days
Usually clear by day 30. Blood-pressure and potassium changes emerge over the same window.
Mouth ulcer healing
4–8 days
Typically complete with 1% or 5% topical preparations.

Benefits

Contraindications
  • Pregnancy at any stage, and breastfeeding
  • Uncontrolled hypertension (systolic above 140 mmHg or diastolic above 90 mmHg on treatment)
  • Heart failure of New York Heart Association Class II or worse
  • Chronic kidney disease stage 3 or beyond (estimated glomerular filtration rate below 60 mL/min/1.73 m²)
  • Cirrhosis with ascites, or Child-Pugh Class B or C liver disease
  • Baseline serum potassium below 3.5 mmol/L from any cause
  • Primary aldosteronism, Liddle syndrome, or apparent mineralocorticoid excess
  • Hormone-sensitive cancers of the breast, uterus, or prostate
  • Men actively treating low testosterone
  • Digoxin
Key Interactions
  • Thiazide and loop diuretics (hydrochlorothiazide, indapamide, furosemide)
  • Corticosteroids (prednisone, hydrocortisone, topical or inhaled steroids)
  • Blood-pressure drugs of every class (ACE inhibitors, angiotensin receptor blockers, calcium-channel blockers)
  • Spironolactone and eplerenone (mineralocorticoid receptor blockers)
  • Warfarin
  • Stimulant laxatives (senna, bisacodyl) and over-the-counter potassium-wasting products
  • Over-the-counter non-steroidal anti-inflammatory drugs (ibuprofen, naproxen)
  • Supplements with additive potassium-lowering or pressure-raising effects (high-dose caffeine, yohimbine, bitter orange, dandelion or juniper as diuretics)
  • Supplements with additive mineralocorticoid or steroid effects (high-dose DHEA, adrenal glandular products)

Risk & Side Effects

  • High: Elevated blood pressure; hypokalemia; fluid retention and edema
  • Medium: Harm to the developing offspring after use in pregnancy
  • Low: Cardiac arrhythmia and cardiac events; hypokalemic myopathy and rhabdomyolysis; reduced serum testosterone in men; unpredictable herb–drug interactions
  • Speculative: Estrogen-receptor activity in hormone-sensitive tissue

Monitoring

Marker Target Why
Serum potassium 4.2–4.8 mmol/L First and most sensitive marker of mineralocorticoid excess
Blood pressure (home, seated) Below 120/80 mmHg Directly tracks the principal dose-limiting effect
Plasma renin activity 0.5–2.0 ng/mL/hour Suppression confirms licorice is driving mineralocorticoid activity
Serum aldosterone 4–20 ng/dL Falls alongside renin, confirming the mechanism rather than another cause of hypertension
Serum sodium 137–142 mmol/L Rises with sodium retention, often before weight or pressure change
Serum magnesium (red blood cell) 5.0–6.5 mg/dL Magnesium is lost alongside potassium and its depletion blocks potassium repletion
Alanine aminotransferase 10–26 U/L (women), 10–33 U/L (men) Tracks the hepatic benefit claimed for licorice in liver disease
Total testosterone 600–900 ng/dL (men), 15–45 ng/dL (women) Detects the androgen-lowering effect, unwanted in men and intended in women
Morning salivary cortisol 0.10–0.30 µg/dL at waking Shows whether cortisol exposure is being extended as intended
Body weight No established target; track change from the individual's own baseline A 1–2 kg gain without diet change is the earliest sign of fluid retention

Cadence: Potassium and blood pressure at baseline, 2 weeks and 4 weeks, then every 3 months while use continues; first recheck moves to week 1 with concurrent diuretics, corticosteroids, or antihypertensives. Deglycyrrhizinated preparations need no electrolyte schedule; annual routine bloodwork is sufficient.

Qualitative Assessment

  • Facial, hand, and ankle puffiness, compared against the baseline photograph
  • Muscle cramps, twitching, or unusual weakness climbing stairs
  • Morning energy and the time of day at which alertness fades
  • Sleep onset latency and night waking, particularly after any evening dose
  • Heartburn, regurgitation, and post-meal fullness, if that was the target
  • Headache, particularly a new pattern of morning headache